March 10, 2017 / 1:28 PM / 5 months ago

BRIEF-Endocyte Q4 loss per share $0.26

March 10 (Reuters) - Endocyte Inc

* Endocyte reports fourth quarter and year end 2016 financial results and provides clinical and pipeline update

* Q4 loss per share $0.26

* Q4 earnings per share view $-0.25 -- Thomson Reuters I/B/E/S

* Endocyte inc- anticipates its cash balance at end of 2017 to be approximately $100 million

* Endocyte inc- also anticipate receiving additional clinical data on ec1169 and ec1456, during 2017

* Endocyte inc- expect to file investigational new drug application for ec2629 in mid 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below